Ditchcarbon
  • Contact
  1. Organizations
  2. European Molecular Biology Laboratory
Public Profile
Research Services
DE
updated a month ago

European Molecular Biology Laboratory Sustainability Profile

Company website

The European Molecular Biology Laboratory (EMBL) is a premier research institution headquartered in Germany, with major operational regions across France, Italy, Spain, and the United Kingdom. Founded in 1974, EMBL has established itself as a leader in molecular biology, focusing on areas such as genomics, proteomics, and bioinformatics. EMBL offers a range of core services, including advanced training, cutting-edge research facilities, and collaborative projects that drive innovation in life sciences. Its unique approach combines interdisciplinary research with state-of-the-art technology, positioning EMBL at the forefront of scientific discovery. With numerous accolades and a strong reputation in the global scientific community, EMBL continues to contribute significantly to advancements in molecular biology, fostering collaboration and excellence in research across Europe and beyond.

DitchCarbon Score

How does European Molecular Biology Laboratory's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

36

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

European Molecular Biology Laboratory's score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

Let us know if this data was useful to you

European Molecular Biology Laboratory's reported carbon emissions

In 2023, the European Molecular Biology Laboratory (EMBL) reported total carbon emissions of approximately 51,713,000 kg CO2e. This figure includes 2,478,000 kg CO2e from Scope 1 emissions, 8,852,000 kg CO2e from Scope 2 emissions, and a significant 40,383,000 kg CO2e from Scope 3 emissions. The combined Scope 1 and 2 emissions totalled about 11,349,000 kg CO2e. Comparatively, in 2022, EMBL's total emissions were about 56,776,000 kg CO2e, with Scope 1 emissions at 2,986,000 kg CO2e, Scope 2 at 9,838,000 kg CO2e, and Scope 3 at 43,952,000 kg CO2e. This indicates a reduction in total emissions of approximately 5,063,000 kg CO2e from 2022 to 2023. EMBL has not disclosed any specific reduction targets or initiatives, nor does it appear to have cascaded data from a parent organisation. The laboratory's commitment to sustainability is evident in its emissions reporting, although no formal climate pledges or SBTi targets have been established. Overall, EMBL's emissions data reflects a significant reliance on Scope 3 emissions, which typically encompass indirect emissions from the value chain, highlighting an area for potential future focus in their climate strategy.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
2,986,000
0,000,000
Scope 2
9,838,000
0,000,000
Scope 3
43,952,000
00,000,000

How Carbon Intensive is European Molecular Biology Laboratory's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. European Molecular Biology Laboratory's primary industry is Research Services, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is European Molecular Biology Laboratory's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for European Molecular Biology Laboratory is in DE, which has a medium grid carbon intensity relative to other regions.

European Molecular Biology Laboratory's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

European Molecular Biology Laboratory has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare European Molecular Biology Laboratory's Emissions with Industry Peers

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Illumina

US
•
Research and development services (73)
Updated 7 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Wellcome Trust

GB
•
Membership organisation services n.e.c. (91)
Updated 7 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy